Economic Evaluation of Desirudin vs Heparin in Deep Vein Thrombosis Prevention after Hip Replacement Surgery

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.13, Iss.1 Part 2, 1998-01, pp. : 111-118

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Desirudin Compared with a Low Molecular Weight Heparin in the Prevention of Deep Vein Thrombosis after Total Hip Replacement Surgery

By Levin L-å.

PharmacoEconomics, Vol. 19, Iss. 5, 2001-01 ,pp. : 589-597

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of a Low-Molecular-Weight Heparin in Prolonged Prophylaxis Against Deep Vein Thrombosis After Total Hip Replacement

By Detournay B.

PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. : 81-89

Adis International

Access to resources Recommend Favorite

Desirudin vs heparin: effects on thrombin

Inpharma, Vol. 1, Iss. 1355, 2002-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Heparin: Thrombocytopenia with arterial thrombosis and deep vein thrombosis: 2 case reports

Reactions Weekly, Vol. 1, Iss. 1242, 2009-01 ,pp. : 27-28

Adis International

Access to resources Recommend Favorite

Apixaban: A Review of its Use in the Prevention of Venous Thromboembolism After Knee or Hip Replacement Surgery

By Deeks Emma D.

Drugs, Vol. 72, Iss. 9, 2012-06 ,pp. : 1271-1291

Adis International

Access to resources Recommend Favorite